Cortex Pharmaceuticals is a clinical-stage specialty pharmaceutical company chiefly engaged in the discovery, development and commercialization of positive AMPA-type glutamate receptor modulators. The company has created a class of proprietary pharmaceuticals called AMPAKINE compounds, which act to increase the strength of signals at connections between brain cells. Recent research has explored the use of AMPAKINE compounds for potentially treating central sleep apnea and treating or preventing respiratory depression caused by opioid analgesics, anesthetic agents and benzodiazepines. For more information, visit the company’s Web site at www.cortexpharm.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: